US HB2951 | 2011-2012 | 112th Congress
Status
Sponsorship: Partisan Bill (Republican 30-1)
Status: Introduced on September 15 2011 - 25% progression, died in committee
Action: 2011-09-20 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 15 2011 - 25% progression, died in committee
Action: 2011-09-20 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Patients First Act of 2011 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act. Requires the Secretary to issue guidelines implementing this Act to ensure that any research (including any clinical trial) supported under this Act: (1) is clearly consistent with the standards established in this Act, if conducted using human cells; and (2) is prioritized in terms of potential for near-term clinical benefit in human patients.Requires the Secretary to report on peer reviewed stem cell research proposals that were not funded.
Title
Patients First Act of 2011
Sponsors
| Rep. Randy Forbes [R-VA] | Rep. Steve Austria [R-OH] | Rep. Diane Black [R-TN] | Sen. Marsha Blackburn [R-TN] |
| Rep. Charles Boustany [R-LA] | Rep. Francisco Canseco [R-TX] | Rep. Mike Coffman [R-CO] | Rep. Renee Ellmers [R-NC] |
| Rep. John Fleming [R-LA] | Rep. Trent Franks [R-AZ] | Rep. Vicky Hartzler [R-MO] | Rep. Jeb Hensarling [R-TX] |
| Rep. Tim Huelskamp [R-KS] | Rep. Bill Huizenga [R-MI] | Rep. Bill Johnson [R-OH] | Rep. Steve King [R-IA] |
| Rep. Doug Lamborn [R-CO] | Rep. Jeffrey Landry [R-LA] | Sen. James Lankford [R-OK] | Rep. Robert Latta [R-OH] |
| Rep. Daniel Lipinski [D-IL] | Rep. Jeff Miller [R-FL] | Rep. Alan Nunnelee [R-MS] | Rep. Mike Pence [R-IN] |
| Rep. Joseph Pitts [R-PA] | Rep. David Roe [R-TN] | Rep. Dennis Ross [R-FL] | Rep. Jean Schmidt [R-OH] |
| Rep. Christopher Smith [R-NJ] | Rep. Lynn Westmoreland [R-GA] | Rep. Robert Wittman [R-VA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2011-09-20 | House | Referred to the Subcommittee on Health. |
| 2011-09-15 | House | Referred to the House Committee on Energy and Commerce. |
Subjects
Administrative law and regulatory procedures
Cell biology and embryology
Department of Health and Human Services
Government studies and investigations
Health
Medical ethics
Medical research
Research administration and funding
Cell biology and embryology
Department of Health and Human Services
Government studies and investigations
Health
Medical ethics
Medical research
Research administration and funding
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/112th-congress/house-bill/2951/all-info |
| Text | https://www.congress.gov/112/bills/hr2951/BILLS-112hr2951ih.pdf |
